First registration of ODI Pharma’s new share issue completed
ODI Pharma AB's ("ODI Pharma" or "Company") recently completed new share issue was significantly oversubscribed and the Company will through the issue receive SEK 25 million before issue costs and around 1,360 new shareholders. For the listing date to take place on the communicated date, the new share issue has been partially registered at the Swedish Companies Registration Office. 2,579,114 shares out of the total of 2,270,000 shares that were subscribed in the new share issue, have now been registered and will be made available for trading on the 23rd of January 2020. The new share issue’s